Press Releases on January 8, 2025 - EIN Presswire - Press Release Distribution Service

Published on January 8, 2025 - 13:00 GMT

Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025

NORWOOD, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced data from its first-in-human dose escalation clinical study conducted in the United States and the United …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on January 8, 2025 - 13:00 GMT

Tenvie Therapeutics Launches with $200 Million to Deliver Breakthrough Small Molecule Therapies

Advancing a deep pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseases Led by expert R&D leadership team with proven ability to develop therapies for CNS and peripheral diseases ARCH Venture Partners, F- …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on January 8, 2025 - 13:00 GMT

STACK Infrastructure Advances Data Center Safety and Releases Breaker Guard Design into Public Domain

DENVER, Jan. 08, 2025 (GLOBE NEWSWIRE) -- STACK Infrastructure (“STACK”), the digital infrastructure partner to the world’s most innovative companies and a leading global developer and operator of data centers is pleased to announce the release of a safety …

Distribution channels: Media, Advertising & PR, Technology ...

Published on January 8, 2025 - 13:00 GMT

Kratos Awarded $48 Million Contract for Geolocation Global Support Services

SAN DIEGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in the defense, national security and global markets, announced that it was awarded a Geolocation Global Support Services (GGSS …

Distribution channels: Aviation & Aerospace Industry, Business & Economy ...

Published on January 8, 2025 - 13:00 GMT

Cellebrite Announces Participation in the 27th Annual Needham & Company Growth Conference

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the Company will participate in the …

Distribution channels: Culture, Society & Lifestyle, Telecommunications ...

Published on January 8, 2025 - 13:00 GMT

Magna International Inc. Announces Date for Q4 & Year End 2024 Results and 2025 Outlook Webcast

AURORA, Ontario, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Magna International Inc. (TSX:MG) (NYSE:MGA) MAGNA INTERNATIONAL INC. ANNOUNCES DATE FOR Q4 & YEAR END 2024 RESULTS and 2025 OUTLOOK WEBCAST FRIDAY, FEBRUARY 14, 2025 @ 8:00 AM ET LIVE AUDIO …

Distribution channels: Automotive Industry, Culture, Society & Lifestyle ...

Published on January 8, 2025 - 13:00 GMT

COUR Pharmaceuticals Secures FDA Orphan Drug Designation for CNP-104 in Primary Biliary Cholangitis

CHICAGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- COUR Pharmaceuticals, a clinical-stage biotechnology company developing ﬁrst-in-class, disease-modifying therapies designed to induce antigen-speciﬁc tolerance for immune-mediated diseases, has secured Orphan Drug …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 8, 2025 - 13:00 GMT

Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287

BETHESDA, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 8, 2025 - 13:00 GMT

Bitcoin Depot Expands BTM Network Through Partnership with Prominent Texas Convenience Store Chain

ATLANTA, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Bitcoin Depot Inc. (“Bitcoin Depot” or the “Company”) (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced the deployment of 50 additional Bitcoin ATMs in …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on January 8, 2025 - 13:00 GMT

Bitterroot Bio Reports Data on Safety and Target Engagement from Phase 1 First-in-Human Study of BRB-002 in Healthy Volunteers

BRB-002 was safe at all doses tested, with no SAEs reported Phase 2 proof-of-concept study in patients with established atherosclerosis is expected to initiate in 1H 2025 PALO ALTO, Calif. and NEEDHAM, Mass. and MELBOURNE, Australia, Jan. 08, 2025 (GLOBE …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on January 8, 2025 - 13:00 GMT

Noema Pharma Appoints Michael Samar as Chief Financial Officer

BASEL, Switzerland, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, today announced the appointment of Michael Samar as Chief Financial Officer. “We are …

Distribution channels: Companies, Technology ...

Published on January 8, 2025 - 13:00 GMT

Acres Debuts Layer Library: Combine and Visualize Land Data Seamlessly

Fayetteville, Ark., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Acres, a leading land data and mapping platform, has launched Layer Library, a groundbreaking feature that enables users to import and visualize public and proprietary datasets alongside Acres’ built-in …

Distribution channels: Media, Advertising & PR ...

Published on January 8, 2025 - 13:00 GMT

Palvella Therapeutics Announces First Patients Dosed in Phase 2 TOIVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (...

Phase 2 single-arm, baseline-controlled trial evaluating QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for the treatment of cutaneous venous malformations (cutaneous VMs) to enroll approximately 15 subjects at leading vascular anomaly centers …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 8, 2025 - 13:00 GMT

authID Receives Industry Luminary Classification in The Prism Project’s 2024 Biometric Digital Identity Flagship Report

authID’s deterministic biometric authentication products recognized for providing the highest level of proficiency in the Identity Proofing and Verification category DENVER, COLORADO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID), a leading …

Distribution channels: IT Industry ...

Published on January 8, 2025 - 13:00 GMT

LifeVantage Announces Preliminary Second Quarter Revenue Results and Raises Fiscal 2025 Revenue Guidance

SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced preliminary revenue results …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Published on January 8, 2025 - 13:00 GMT

Mineralys Therapeutics Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients with Hypertension

– Estimated 54 million people suffer from obstructive sleep apnea in the U.S. including 30-50% of adults with hypertension, both conditions associated with excess morbidity and mortality – – Obstructive sleep apnea represents Mineralys’ third precision, …

Distribution channels: Technology ...

Published on January 8, 2025 - 13:00 GMT

Replimune Announces RP2 Development Program Advances with First Patients Enrolled in Metastatic Uveal Melanoma and Hepatocellular ...

WOBURN, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the first patients have been enrolled in …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 8, 2025 - 13:00 GMT

Unnatural Products Appoints Abbas Kazimi and Mert Aktar to Board of Directors

SANTA CRUZ, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech developing orally-delivered macrocyclic peptides to address previously undruggable targets, announced today the appointment of Abbas Kazimi and Mert Aktar to …

Distribution channels: Companies, Technology ...

Published on January 8, 2025 - 13:00 GMT

Microbot Medical Announces $8.6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

HINGHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 3,788,550 shares of the Company’s common stock at a purchase price of $2.27 …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 8, 2025 - 13:00 GMT

Coherus Management to Present at the 43rd Annual J.P. Morgan Healthcare Conference

REDWOOD CITY, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that senior management will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 5:15 p.m. …

Distribution channels: Culture, Society & Lifestyle, Technology ...